Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5521 AL 5535

Alzheimer's disease: implications of the updated diagnostic and research criteria

Reiman EM, McKhann GM, Albert MS, Sperling RA, Petersen RC, Blacker D.

J Clin Psychiatry. 2011 Sep;72(9):1190-6. doi: 10.4088/JCP.10087co1c.

Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease

Jawhar S, Wirths O, Bayer TA.

J Biol Chem. 2011 Nov 11;286(45):38825-32. doi: 10.1074/jbc.R111.288308. Epub 2011 Sep 29.

Nuclear medicine diagnostic techniques in the era of pathophysiology-based CSF biomarkers for Alzheimer's disease

Weih M, Degirmenci U, Kreil S, Suttner G, Schmidt D, Kornhuber J, Lewczuk P, Kuwert T.

J Alzheimers Dis. 2011;26 Suppl 3:97-103. doi: 10.3233/JAD-2011-0020.

Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage

Drago V, Babiloni C, Bartrés-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, Hårdemark HG, Frisoni GB.

J Alzheimers Dis. 2011;26 Suppl 3:159-99. doi: 10.3233/JAD-2011-0043.

Searching for novel biomarkers using high resolution diffusion tensor imaging

Yassa MA.

J Alzheimers Dis. 2011;26 Suppl 3(Suppl 3):297-305. doi: 10.3233/JAD-2011-0005.

Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments

Reiman EM; Alzheimer's Disease Biomarkers Working Group for the Alliance for Aging Research.

Neurobiol Aging. 2011 Dec;32 Suppl 1(Suppl 1):S44-7. doi: 10.1016/j.neurobiolaging.2011.09.007. Epub 2011 Oct 7.

Clinical trial methodologies for disease-modifying therapeutic approaches

Aisen PS.

Neurobiol Aging. 2011 Dec;32 Suppl 1(Suppl 1):S64-6. doi: 10.1016/j.neurobiolaging.2011.09.008. Epub 2011 Oct 8.

Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk

Sugarman MA, Woodard JL, Nielson KA, Seidenberg M, Smith JC, Durgerian S, Rao SM.

Biochim Biophys Acta. 2012 Mar;1822(3):442-56. doi: 10.1016/j.bbadis.2011.09.016. Epub 2011 Oct 4.

Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits

Di Domenico F, Coccia R, Butterfield DA, Perluigi M.

Biochim Biophys Acta. 2011 Dec;1814(12):1785-95. doi: 10.1016/j.bbapap.2011.10.001. Epub 2011 Oct 12.

Challenges in the development of companion diagnostics for neuropsychiatric disorders

Nikolcheva T, Jäger S, Bush TA, Vargas G.

Expert Rev Mol Diagn. 2011 Nov;11(8):829-37. doi: 10.1586/erm.11.67.

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, Parnetti L, Perret-Liaudet A, Shaw LM, Teunissen C, Wouters D, Blennow K.

Alzheimers Dement. 2012 Jan;8(1):65-73. doi: 10.1016/j.jalz.2011.07.004. Epub 2011 Nov 2.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2012 Feb;8(1 Suppl):S1-68. doi: 10.1016/j.jalz.2011.09.172. Epub 2011 Nov 2.

CSF biomarkers for amyloid and tau pathology in Alzheimer's disease

Rosenmann H.

J Mol Neurosci. 2012 May;47(1):1-14. doi: 10.1007/s12031-011-9665-5. Epub 2011 Nov 5.

Evolution of the diagnostic criteria for degenerative and cognitive disorders

Lopez OL, McDade E, Riverol M, Becker JT.

Curr Opin Neurol. 2011 Dec;24(6):532-41. doi: 10.1097/WCO.0b013e32834cd45b.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias